In this Issue:
LV dyssynchrony in HF and preserved EF
Low-dose landiolol slows heart rate in acute decompensated HF with rapid AF
Transendocardial MSCs and BMCs for ischaemic cardiomyopathy
Low-dose dopamine or nesiritide in acute HF with renal dysfunction
MR-proADM helps predict long-term mortality in stable HF
Anticoagulation and survival in PAH
Clinical profiles and outcomes in chronic HF with COPD
Anakinra improves aerobic exercise capacity in HF with preserved EF
ST2 predicts mortality in acute HF
ST2 vs. Gal-3 for long-term HF risk stratification
Please login below to download this issue (PDF)